PE20001453A1 - Composicion de administracion oral con liberacion controlada de al menos un analgesico - Google Patents

Composicion de administracion oral con liberacion controlada de al menos un analgesico

Info

Publication number
PE20001453A1
PE20001453A1 PE2000000003A PE0000032000A PE20001453A1 PE 20001453 A1 PE20001453 A1 PE 20001453A1 PE 2000000003 A PE2000000003 A PE 2000000003A PE 0000032000 A PE0000032000 A PE 0000032000A PE 20001453 A1 PE20001453 A1 PE 20001453A1
Authority
PE
Peru
Prior art keywords
analgesic
composition
microtablets
cellulose
polymer
Prior art date
Application number
PE2000000003A
Other languages
English (en)
Inventor
Johannes Bartholomaus
Jurgen Betzing
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20001453A1 publication Critical patent/PE20001453A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE UN ANALGESICO OPIOIDE TAL COMO HIDROMORFONA, OXICODON, LEVORFANOL, METADONA, DIHIDROCODEINA, FENTANIL, CODEINA, DIHIDROMORFINA, PETIDINA, PIRITRAMIDA, TILIDINA, BUPRENORFINA; DE PREFERENCIA TRAMADOL Y MORFINA. LA COMPOSICION ESTA CONSTITUIDA POR MICROTABLETAS CON DIAMETRO MENOR DE 3 mm CON AL MENOS UN REVESTIMIENTO RETARDANTE ESTANDO EL ANALGESICO DISTRIBUIDO EN UNA MATRIZ RETARDANTE CON AL MENOS UN POLIMERO (ETERES DE CELULOSA, ESTERES DE CELULOSA O RESINAS ACRILICAS), CERA, ACEITE, GRASA, ACIDO GRASO, ESTER; b)UN REVESTIMIENTO RETARDANTE DE CERA O POLIMERO TAL COMO RESINAS ACRILICAS O DERIVADOS DE CELULOSA DE PREFERENCIA ALQUILCELULOSA SOLUBLE EN AGUA. LA COMPOSICION ESTA ENVASADA EN CAPSULAS QUE CONTIENEN UNA CANTIDAD DEFINIDA DE MICROTABLETAS CORRESPONDIENTE A LA DURACION DE LIBERACION Y A LA CANTIDAD DE ANALGESICO A LIBERAR O LAS MICROTABLETAS SE PUEDEN COMPRIMIR CON ADITIVOS O AUXILIARES PARA FORMAR UNA TABLETA. LA COMPOSICION LIBERA EL ANALGESICO HASTA MAS DE 75% EN 30 MINUTOS
PE2000000003A 1999-01-18 2000-01-04 Composicion de administracion oral con liberacion controlada de al menos un analgesico PE20001453A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19901683A DE19901683B4 (de) 1999-01-18 1999-01-18 Analgetikum mit kontrollierter Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
PE20001453A1 true PE20001453A1 (es) 2000-12-23

Family

ID=7894562

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000003A PE20001453A1 (es) 1999-01-18 2000-01-04 Composicion de administracion oral con liberacion controlada de al menos un analgesico

Country Status (17)

Country Link
EP (1) EP1020183A3 (es)
JP (1) JP2000212069A (es)
KR (1) KR20000071245A (es)
CN (1) CN1270028A (es)
AR (1) AR021934A1 (es)
AU (1) AU777330B2 (es)
CA (1) CA2295469A1 (es)
CO (1) CO4910117A1 (es)
DE (1) DE19901683B4 (es)
HU (1) HUP0000137A3 (es)
IL (1) IL134075A0 (es)
NZ (1) NZ502260A (es)
PE (1) PE20001453A1 (es)
PL (1) PL337868A1 (es)
RU (1) RU2244541C2 (es)
SK (1) SK652000A3 (es)
ZA (1) ZA200000171B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19901687B4 (de) * 1999-01-18 2006-06-01 Grünenthal GmbH Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
SK285128B6 (sk) * 1999-12-28 2006-07-07 Zentiva, A. S. Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
CN100356907C (zh) * 2001-06-08 2007-12-26 恩德制药公司 利用丙烯酸酯聚合物的控释剂型和其制备方法
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
CN100336501C (zh) * 2003-08-06 2007-09-12 健乔信元医药生技股份有限公司 醋炎痛缓释性圆粒组成物及制备方法
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2007048219A2 (en) 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
DE102008056312A1 (de) 2008-11-07 2010-05-12 Biogenerics Pharma Gmbh Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5138M (es) * 1966-01-26 1967-06-05
CA1341504C (en) * 1988-03-25 2006-04-11 Jun Akimitsu Substituted superconductive bi-sr-ca-cu oxide and bi-sr-ca-ln-cu oxide compositions
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
IT1243341B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei
EP2036558A3 (en) * 1993-10-07 2010-04-28 Euro-Celtique S.A. Orally administrable opioid formulations having extended duration of effect
DE69429710T2 (de) * 1993-11-23 2002-08-08 Euro Celtique Sa Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe
US6306438B1 (en) * 1997-07-02 2001-10-23 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
US6156342A (en) * 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form

Also Published As

Publication number Publication date
PL337868A1 (en) 2000-07-31
DE19901683A1 (de) 2000-07-20
JP2000212069A (ja) 2000-08-02
EP1020183A2 (de) 2000-07-19
HUP0000137A2 (hu) 2001-02-28
DE19901683B4 (de) 2005-07-21
NZ502260A (en) 2002-02-01
RU2244541C2 (ru) 2005-01-20
SK652000A3 (en) 2000-08-14
IL134075A0 (en) 2001-04-30
CA2295469A1 (en) 2000-07-18
HU0000137D0 (en) 2000-03-28
AU777330B2 (en) 2004-10-14
CO4910117A1 (es) 2000-04-24
HUP0000137A3 (en) 2001-03-28
KR20000071245A (ko) 2000-11-25
CN1270028A (zh) 2000-10-18
AU1010700A (en) 2000-07-20
AR021934A1 (es) 2002-09-04
ZA200000171B (en) 2000-08-07
EP1020183A3 (de) 2000-09-20

Similar Documents

Publication Publication Date Title
PE20001453A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
PE20001395A1 (es) Composicion de administracion oral con liberacion controlada de un analgesico opioide
KR930005616A (ko) 의약용 방출조절 매트릭스
MX348361B (es) Formulaciones resistentes al abuso.
MX347753B (es) Formulaciones resistentes al abuso.
MXPA06008352A (es) Una composicion farmaceutica.
RU2010129907A (ru) Лекарственная форма с контролируемым высвобождением, предотвращающая неправильное употребление
BR9812523A (pt) Processo para preparar um dispositivo de distribuição transdérmica, dispositivo de distribuição transdérmica, e, uso de um esteróide como um aditivo
GEP20074022B (en) Pharmaceutical formulations comprising oxycodone and naloxone
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
WO2013016697A3 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
IL137100A0 (en) Tts containing an antioxidant
PE20091898A1 (es) Particulados
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
MX2012011355A (es) Parche de suministro transdermico.
AR076540A1 (es) Composiciones de comprimidos de desintegracion oral que comprenden combinaciones de analgesicos no- opioides y opioides, forma de dosificacion. metodo de preparacion. metodo para tratar dolor
RU2000101023A (ru) Анальгетик с контролируемым высвобождением активного вещества
WO2007103200A3 (en) Oral controlled release formulation for sedative and hypnotic agents
ATE413865T1 (de) Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür
ATE390138T1 (de) Dipyridamol enthaltende zusammensetzungen mit verlängerter freisetzung und verfahren zu deren herstellung
NZ603497A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2007006775A (es) Composiciones estables de fenofibrato con esteres de acido graso.
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
NZ334399A (en) Pharmaceutical microspheres of valproic acid and vehicle like glycerol for oral administration
WO2005025488A3 (en) Methods for the controlled delivery of pharmacologically active compounds

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed